Skip to content
★ Sign in to follow
JS

Joel S. Kanter

Executive
WaferGen Bio-systems, Inc.I Flow Corp /DE/Encore Medical CorpProspect Medical Holdings IncEcho Healthcare Acquisition Corp.Aevi Genomic Medicine, LLCLifesciences Opportunities Inc
Total declarations
76
Companies
7
▲ Purchases (3 ops.)
€162k
▼ Sales (14 ops.)
€2.2M

Latest filing published 01 Mar 2017 for WaferGen Bio-systems, Inc., €60k.

Insider track record

Disclosed buys
3
Disclosed sells
14
Signal history

No signal scores available.

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Joel S. Kanter: trading record in brief

Filings by Joel S. Kanter span 7 companies, the busiest being Echo Healthcare Acquisition Corp., I Flow Corp /DE/ and WaferGen Bio-systems, Inc. Over a trading history stretching from 2 January 2006 to 28 February 2017, the count stands at 76 filings.

The open-market side counts 3 purchases for €162k alongside 14 sales for €2.2M. Taken together, the sales exceed the purchases by €2.0M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 25 share grants and 18 option exercises.

Half of the purchases are above €54k and half below.

The record was last updated on 1 March 2017 with a transaction (€60k) in WaferGen Bio-systems, Inc. The clock since the last published purchase (20 March 2009) now reads 6,442 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Joel S. Kanter

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations63 total

25 of 63 declarations